RAHUL SINGH HADA

About

A seasoned scientist with an impressive broad spectrum and versatile experience in contemporary and futuristic research methodologies in domains of Life Sciences such as Cell Biology, Mammalian Cell Culture, Parasitology, Molecular Biology, Microbiology, Drug and Vaccine Development and Pre-Clinical Studies.

During my research undertakings I have worked in close collaboration with the National Institute of Immunology, Delhi University, Jamia Millia Islamia, Jawahar Lal Nehru University and due to my versatile exposure I have groomed myself under some exemplary and experienced mentors.

Our group has published several research papers in reputed international peer review journals.

Our work in Calcium Homeostasis and Small Molecule Therapeutics has shown promising results towards drug development research addressing drug resistance.

Currently I am leading a team in Micro CRISPR (Meril) working actively in research and development of CAR-T and contributing in the Micro CRISPR's domain to transform the research into realistic therapies. I have gained expertise in CAR-T platforms both Autologous as well as Allogenic (Off the Shelf) involving active genetic engineering involving CRISPR-Cas9 based genetic manipulation.

I am confident and working in a role to quench my thirst for novel research undertakings in a professionally sound environment by getting associated with a group of leading and seasoned researchers and top notch scientists working in the domain of Life Science and Biotechnology.

Come on Bharat! Dream Big. Achieve Enormous.

Employment

• Meril Life Sciences (India) Manager
  2025 - Present
• Shiv Nadar University PhD Scholar
  2017 - 2024
• Shiv Nadar University Research Scholar
  2017 - 2017
• Talwar Research Foundation Junior Research Fellow
  2014 - 2017

Education

• Shiv Nadar University PhD
  2017 - 2024
• Jiwaji University Master of Science
  2012 - 2014

Projects & Funding

Projects & funding information is unavailable.

Publications (5)

• Highly potent anti-malarial activity of benzopyrano(4,3-b)benzopyran derivatives and in silico interaction analysis with putative target Plasmodium falciparum lactate dehydrogenase.
  Journal of biomolecular structure & dynamics 2021 DOI: 10.1080/07391102.2020.1868336
  +Save
• Pathogenic Pore Forming Proteins of Plasmodium Triggers the Necrosis of Endothelial Cells Attributed to Malaria Severity
  Toxins 2021 DOI: 10.3390/toxins13010062
  +Save
• Identification and structure-activity relationship (SAR) studies of carvacrol derivatives as potential anti-malarial against Plasmodium falciparum falcipain-2 protease.
  Bioorganic chemistry 2020 DOI: 10.1016/j.bioorg.2020.104142
  +Save
• Plasmodium Perforin-Like Protein Pores on the Host Cell Membrane Contribute in Its Multistage Growth and Erythrocyte Senescence.
  Frontiers in cellular and infection microbiology 2020 DOI: 10.3389/fcimb.2020.00121
  +Save
• Inhibition of Hemoglobin Degrading Protease Falcipain-2 as a Mechanism for Anti-Malarial Activity of Triazole-Amino Acid Hybrids.
  Current topics in medicinal chemistry 2020 DOI: 10.2174/1568026620666200130162347
  +Save